Table 1.
SNP | Cancer Type | Sequence; Location; Consequence (If Known) | Prognostic | Cohort | Reference |
---|---|---|---|---|---|
rs28362491 | Colorectal | ATTG del; -94 promoter region; reduces promoter activity and nuclear protein binding ability, decreasing NFKB1 expression | Disadvantageous | Swedish; Malaysian | [68,69] |
Gastric | Disadvantageous | Japanese; Chinese | [36,37] | ||
Liver | Disadvantageous | Taiwanese | [70] | ||
Bladder | Disadvantageous | Chinese | [71] | ||
Esophageal | Disadvantageous | Northern Indian | [72] | ||
Thyroid | Disadvantageous | Chinese | [73] | ||
Melanoma | Disadvantageous | Brazilian, Swedish | [74,75] | ||
Nasopharyngeal | Disadvantageous | Chinese | [76] | ||
Oral | Disadvantageous | Taiwanese | [77] | ||
Prostate | Advantageous | Canadian | [78] | ||
Ovarian | Advantageous | Greek | [55] | ||
Cervical | Advantageous | Chinese, Indian | [79,80] | ||
rs230496 | Liver | AG and GG genotypes | Disadvantageous | Chinese | [81] |
rs230525 | Liver | GA genotypes | Disadvantageous | Chinese | [81] |
rs230530 | Liver | AA genotypes | Disadvantageous | Chinese | [81] |
rs78696119 | Gastric | GG genotypes; increased inflammatory cell infiltration, diffuse type gastric cancer and cancer progression | Disadvantageous | Japanese | [36] |
rs72696119 | Gastric | GG and del/del genotypes; -449 in 5′ UTR region; muscle layer tumour invasion and lymph node metastasis | Disadvantageous | Japanese | [36] |
rs4648068 | Gastric | GG genotype; intron 12; increased incorporation of the H3K9me1 and H3K4me1 histones, increased chemomodification, enhanced transcriptional activity, cell proliferation and motility | Disadvantageous | Chinese | [37,82] |
rs230510 | Gastric | A genotype; intronic region | Advantageous | Japanese, US | [83] |
Ovarian | T genotype; intron 12 | Advantageous | Chinese | [84] | |
rs230521 | Ovarian | G genotype; intron 4 | Advantageous | Chinese | [84] |